• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • Our Pillars
        • ARIKAYCE®
        • Brensocatib
        • TPIP
        • Early-Stage Research
      • Pipeline
      • Clinical Trials
      • Investigator-Initiated Research

    Our Research

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home/Science/Clinical Trials

Clinical Trials

Channel passion into potential

Our clinical trials help us investigate our product candidates’ novel capabilities.

To learn more about our current clinical trials, including eligibility, locations, and the process for potentially participating in a study, visit clinicaltrials.gov in the U.S., 
clinicaltrialsregister.eu in the EU, or https://jrct.niph.go.jp in Japan.

Our Commitment to Clinical Trial Transparency

At Insmed, we are deeply committed to ensuring that our clinical research is conducted responsibly and transparently, in full compliance with applicable laws and regulations, while protecting patient data. We are proud to have dedicated and trained staff to ensure timely registration of clinical trials and communication of our research results, and we work closely with external experts and thought leaders to ensure our work reflects the latest clinical and scientific advances.

Our current clinical trial transparency practices include:

Data Privacy

As guardians of data about the patients who use our medicines, as well as their caregivers and the healthcare professionals who serve them, we are committed to handling personal data in accordance with global laws and regulations that govern data protection and privacy.

Clinical Trial Registration

Insmed registers company-sponsored Phase 1 to 4 clinical trials on public clinical registry sites as required by global laws and regulations.

To learn more about our current clinical trials, please visit the following websites:

  • U.S.: www.clinicaltrials.gov
  • Europe: www.clinicaltrialsregister.eu
  • Japan: https://jrct.niph.go.jp

Clinical Trial Results

Insmed discloses company-sponsored Phase 1 to 4 clinical trial results on public registries in compliance with global results disclosure laws and regulations.    

To find clinical trial results for our completed trials, please visit the following websites:

  • U.S.: www.clinicaltrials.gov
  • Europe: clinicaltrialsregister.eu
  • Japan: https://jrct.niph.go.jp

Clinical Trial Lay Language Summary Results

In addition to posting results from our clinical trials, Insmed discloses lay language summary results on https://www.trialsummaries.com to help ensure that our results are understandable to patients and other general audiences.

Our clinical trials

Aspen

NCFBE

The Phase 3 ASPEN study of patients with non-cystic fibrosis bronchiectasis (NCFBE) is currently underway.

Learn more about the study

NTM LUNG DISEASE CAUSED BY MAC

If you have nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex (MAC), you may be eligible for our clinical trial.

See if you may qualify

PULMONARY HYPERTENSION

If you have pulmonary hypertension associated with interstitial lung disease (PH-ILD) or pulmonary arterial hypertension (PAH), you may be eligible for an Insmed study.

To learn about study sites near you, email medicalinformation@Insmed.com, call 1-844-446-7633 (within the United States), or visit https://insmedv2stag.wpengine.com/med-info/ for a list of phone numbers outside the United States.

CRSsNP

If you have chronic rhinosinusitis without nasal polyps (CRSsNP), you may be eligible for the Phase 2 BiRCh study.

See if you may qualify

Questions about our clinical trials?

Reach out to us

Footer

Insmed
LinkedInTwitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Our Science
    • Our Pillars
      • ARIKAYCE®
      • Brensocatib
      • TPIP
      • Early-Stage Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2023 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy Do Not Sell or Share My Personal Information

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Science
    • Our Pillars
      • ARIKAYCE®
      • Brensocatib
      • TPIP
      • Early-Stage Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filiings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2021 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy